Intrepid Capital Management’s AbbVie ABBV Stock Holding History

Intrepid Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$785K	Buy	3,118 +103	+3%	+$22.2K	0.28%	70
2026 Q1	$656K	Buy	3,015 +31	+1%	+$6.88K	0.25%	72
2025 Q4	$682K	Buy	2,984 +1	+0%	+$228	0.26%	69
2025 Q3	$691K	Buy	2,983 +306	+11%	+$62.3K	0.27%	70
2025 Q2	$497K	Buy	2,677 +56	+2%	+$10.4K	0.2%	77
2025 Q1	$549K	Buy	2,621 +969	+59%	+$188K	0.27%	68
2024 Q4	$294K	Buy	1,652 +142	+9%	+$26.1K	0.15%	79
2024 Q3	$298K	Buy	1,510 +138	+10%	+$25.8K	0.17%	84
2024 Q2	$235K	Buy	1,372 +167	+14%	+$27.7K	0.15%	85
2024 Q1	$219K	Buy	1,205 +256	+27%	+$44.1K	0.14%	88
2023 Q4	$147K	Buy	949 +96	+11%	+$14K	0.1%	93
2023 Q3	$127K	Sell	853 -45	-5%	-$6.61K	0.09%	92
2023 Q2	$121K	Buy	+898	New	+$132K	0.09%	97

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Intrepid Capital Management's ABBV Position: Q2 2026 in Review

Intrepid Capital Management increased its AbbVie (ABBV) stake by 3.4% in Q2 2026, buying an estimated $22.2K and bringing the position to 3,118 shares worth $785K. The position accounts for 0.28% of the portfolio, ranked #70.

Intrepid Capital Management first reported a position in ABBV in Q2 2023 and has held it in 13 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Intrepid Capital Management held 3,118 shares of AbbVie worth $785K as of Q2 2026.
Intrepid Capital Management bought 103 AbbVie shares in Q2 2026, an estimated $22.2K.
AbbVie made up 0.28% of Intrepid Capital Management's portfolio in Q2 2026, its #70 holding.
Intrepid Capital Management first reported a position in AbbVie in Q2 2023 and has held it in 13 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Intrepid Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.